OBI-902

OBI-902 · OBI Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-902, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]